Insulet Corporation to Present at Upcoming Investor Conferences
BEDFORD, MA--(Marketwire - June 3, 2010) - Insulet Corporation (
- The Jefferies 2010 Global Life Sciences Conference taking place June 8-11, 2010 at The Grand Hyatt in New York City. Management is scheduled to present an overview of the Company at 2:30 p.m. ET on Thursday, June 10, 2010.
- The William Blair 30th Annual Growth Stock Conference taking place June 15-17, 2010 at the Chicago Four Seasons Hotel. Management is scheduled to present an overview of the Company at 3:30 p.m. ET on Tuesday, June 15, 2010.
During the conference presentations, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcasts of the presentations during these events, please visit: [ http://investors.insulet.com ]. Replays of the webcasts will be available for 30 days.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.